cloud-formulary.com

What It Is

Formulary 4.0 is provided by the Japanese organization “医薬品集制作の大学堂” and is positioned as a cloud-based in-hospital drug formulary built specifically for pharmacists. It is not a general-purpose SaaS product, but a vertical tool for hospital pharmacy DI work, drug information retrieval, and the accumulation of in-house knowledge. The page highlights “10 years of experience in production and maintenance outsourcing,” making it relevant for situations such as pharmacist shortages, work processes that depend too heavily on individual staff, training younger pharmacists, and team-based medical care.

Core Features and Collaboration

The core of the product is to centralize tertiary references, citations from specialist books, links to drug information websites, and hospital-specific local information in the cloud, helping pharmacists quickly find reliable materials. Its features cover alternative drug selection, prompts for same active ingredient / same therapeutic effect / recommendation level, dosage checks for special patient groups, renal and hepatic function considerations, drug interactions, pediatric dosing, off-label dosing, risk evaluation, polypharmacy deprescribing screening, formulation characteristics such as crushing / capsule opening, simple suspension, filter passability, DEHP leaching, and management of extravasation.

For collaboration, each drug has a comment section that can be used for sharing information within the hospital, addressing the common problem of traditional Q&A collections becoming outdated and difficult to reuse.

Pricing, Trial, and Deployment

The page does not disclose specific plans or pricing. It only mentions “transaction flow and plan introduction” and “try it for free first,” so it appears that a free trial or trial application is available. However, the trial duration, feature limitations, and payment model are not specified. The deployment model is clearly cloud-based, with no mention of on-premises deployment, self-hosting, or private cloud. There is also no visible information about APIs, developer documentation, or integration with HIS, electronic medical records, or pharmacy systems.

Pros and Cons

Its main strengths are its strong vertical focus and design around real DI workflows for hospital pharmacists in Japan, especially for institutions that need to quickly locate tertiary references and narrow the gap between junior and senior pharmacists. The outsourced production and maintenance service can also help relieve the burden on pharmacists who lack the capacity to keep materials continuously updated.

The downside is limited disclosure of enterprise SaaS information: there is no pricing, no permission model, no security or compliance explanation, and no details on audit or integration capabilities. Procurement evaluation would still require substantial offline confirmation.

Best Fit and Access from China

It is best suited to Japanese medical institutions, hospital pharmacy departments, DI managers, and night-shift or ward pharmacists. Access from China is unclear; even if accessible, its reference system, drug catalog, regulatory sources, and payment methods are highly localized for Japan. Chinese hospitals should first evaluate alternatives such as local rational drug use systems, clinical pharmacy knowledge bases, and drug information modules built into HIS or pharmacy systems.